5,7-dihydroxytryptamine has been researched along with Chronic Pain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, JD; Ferguson, AR; Irvine, KA; Sahbaie, P | 1 |
| Furukawa, S; Furukawa, Y; Ishikawa, K; Ishikawa, T; Iwanaga, Y; Nakano, M; Okuyama, S; Suenaga, H; Yamagata, H; Yasuda, S; Yoshida, M | 1 |
2 other study(ies) available for 5,7-dihydroxytryptamine and Chronic Pain
| Article | Year |
|---|---|
Loss of diffuse noxious inhibitory control after traumatic brain injury in rats: A chronic issue.
Topics: 5,7-Dihydroxytryptamine; Adrenergic Uptake Inhibitors; Animals; Brain Injuries, Traumatic; Capsaicin; Chronic Pain; Diffuse Noxious Inhibitory Control; Duloxetine Hydrochloride; Male; Neural Pathways; Norepinephrine; Pain Measurement; Rats; Rats, Sprague-Dawley; Reboxetine; Receptors, Adrenergic, alpha-2; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents | 2020 |
Imipramine ameliorates pain-related negative emotion via induction of brain-derived neurotrophic factor.
Topics: 5,7-Dihydroxytryptamine; Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Chronic Pain; Constriction, Pathologic; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Emotions; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Gyrus Cinguli; Imipramine; Male; Phosphorylation; Rats, Sprague-Dawley; Reaction Time; RNA, Messenger; Serotonin; Spinal Cord | 2014 |